-transparent.png){kind=logo}
Between December 1983 and August 1985, 110 cadaver transplants were performed at our institution. All were started on cyclosporine (CsA) and prednisone (P) for immunosuppressive therapy. Of the 110 patients, 46 were converted from CsA to azathioprine (AZA) for a variety of reasons (cost, toxicity, patient preference, prolonged dysfunction posttransplant, or nonresponsive rejection). The course and outcome of these patients are described. The only group of patients who had consistent benefit and stable course following the CsA-to-AZA switch were primary cadaver transplants with stable renal function (serum creatinine less than 2 mg/dl) who were converted an average of 7.97 months posttransplant. All other groups of patients had severe problems or graft loss postconversion.
T A Gonwa, and
D D Nghiem, and
J A Schulak, and
R J Corry
February 1990,
American journal of kidney diseases : the official journal of the National Kidney Foundation,
T A Gonwa, and
D D Nghiem, and
J A Schulak, and
R J Corry
June 1988,
Transplantation proceedings,
T A Gonwa, and
D D Nghiem, and
J A Schulak, and
R J Corry
October 1994,
Transplantation proceedings,
T A Gonwa, and
D D Nghiem, and
J A Schulak, and
R J Corry
October 1992,
Transplantation proceedings,
T A Gonwa, and
D D Nghiem, and
J A Schulak, and
R J Corry
January 1986,
The Journal of heart transplantation,
T A Gonwa, and
D D Nghiem, and
J A Schulak, and
R J Corry
October 1989,
Pediatric nephrology (Berlin, Germany),
T A Gonwa, and
D D Nghiem, and
J A Schulak, and
R J Corry
February 1986,
ANNA journal,
T A Gonwa, and
D D Nghiem, and
J A Schulak, and
R J Corry
February 1989,
Transplantation proceedings,
T A Gonwa, and
D D Nghiem, and
J A Schulak, and
R J Corry
December 1984,
Transplantation,
T A Gonwa, and
D D Nghiem, and
J A Schulak, and
R J Corry
August 1985,
Transplantation proceedings,
